Los Angeles Capital Management
ITCI

Los Angeles Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Los Angeles Capital Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,979
Closed -$730K – 1260
2024
Q3 		$730K Hold
9,979
– – ﹤0.01% 751
2024
Q2 		$683K Sell
9,979
-6,045
-38% -$419K ﹤0.01% 773
2024
Q1 		$1.11M Sell
16,024
-1,550
-9% -$107K ﹤0.01% 664
2023
Q4 		$1.26M Buy
17,574
+2,210
+14% +$127K ﹤0.01% 602
2023
Q3 		$800K Buy
15,364
+371
+2% +$21.6K ﹤0.01% 706
2023
Q2 		$949K Buy
14,993
+1,368
+10% +$85.2K ﹤0.01% 667
2023
Q1 		$738K Sell
13,625
-1,217
-8% -$58.8K ﹤0.01% 749
2022
Q4 		$785K Buy
14,842
+6,788
+84% +$340K ﹤0.01% 773
2022
Q3 		$375K Buy
+8,054
New +$421K ﹤0.01% 1008
2021
Q1 		– Sell
-9,132
Closed -$290K – 1665
2020
Q4 		$290K Buy
+9,132
New +$240K ﹤0.01% 1384
2019
Q1 		– Sell
-51,030
Closed -$581K – 1448
2018
Q4 		$581K Sell
51,030
-20,875
-29% -$337K ﹤0.01% 925
2018
Q3 		$1.56M Sell
71,905
-27,465
-28% -$574K 0.01% 735
2018
Q2 		$1.76M Buy
+99,370
New +$2.02M 0.01% 727
2017
Q3 		– Sell
-60,720
Closed -$754K – 1361
2017
Q2 		$754K Buy
+60,720
New +$704K ﹤0.01% 838

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Los Angeles Capital Management's ITCI Position: Q4 2024 in Review

Los Angeles Capital Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2024, closing a stake of 9,979 shares — an estimated $730K sold.

Los Angeles Capital Management first reported a position in ITCI in Q2 2017 and held it in 14 quarters. The position peaked at $1.76M in Q2 2018. 387 funds tracked by Wall St. Rank hold ITCI as of Q4 2024.

  • Los Angeles Capital Management reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2024 after selling out during the quarter.
  • Los Angeles Capital Management sold 9,979 Intra-Cellular Therapies Inc. shares in Q4 2024, an estimated $730K.
  • Los Angeles Capital Management first reported a position in Intra-Cellular Therapies Inc. in Q2 2017 and held it in 14 quarters.
  • Los Angeles Capital Management's Intra-Cellular Therapies Inc. position peaked at $1.76M in Q2 2018.
  • 387 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2024.

Based on Los Angeles Capital Management's 13F filing for Q4 2024, filed 4 Feb 2025.